shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    DoD Peer Reviewed Cancer, Impact Award

    HT942524PRCRPIPA

    Jamie Shortall Grant Officer

    Opening date 1 May 2024, 12:00AM

    Closing date 26 Sep 2024, 12:00AM

    Funding Opportunity Number: HT942524PRCRPIPA

    Opportunity Category: Discretionary

    Expected Number of Awards: 10

    CFDA Number(s): 12.420 -- Military Medical Research and Development

    Cost Sharing or Matching Requirement: No

    Posted Date: May 01, 2024 12:00:00 AM EDT

    Closing Date: Sep 26, 2024 12:00:00 AM EDT

    Estimated Total Program Funding: 16000000

    Award Ceiling: none

    Award Floor: none

    Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

    Agency Name: Jamie Shortall Grant Officer

    Description:

    The FY24 PRCRP Impact Award supports high-impact research that can accelerate promising findings toward clinical applicability. The intent of the Impact Award mechanism is to fund mature research projects that specifically focus on critical scientific or clinical cancer issues, which have the potential to make a major near-term impact on at least one of the FY24 PRCRP Topic Areas and in at least one of the FY24 PRCRP Overarching Challenges.

    The critical components of this award mechanism are:

    ·            Impact: Research supported by the Impact Award will demonstrate the potential to accelerate promising findings and have a major impact in the near term on an area of paramount importance in cancer. The proposed study should demonstrate potential to improve patient outcomes in at least one of the FY24 PRCRP Topic Areas and in at least one of the FY24 PRCRP Overarching Challenges. Proposed projects may include translational or clinical research, including clinical trials. The potential impact of the proposed research is expected to be near-term, and while it fundamentally may include the next step in research, it must be significant and go beyond an incremental advance. The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient outcomes. The Impact Award is not intended for basic research. Applicants generating preliminary data, basic research, high-risk/high-gain studies should apply to the FY24 PRCRP Idea Award (HT942524PRCRPIA).

    ·            Preliminary Data: The Impact Award is intended to support transformative investigations that leapfrog the cancer research field forward by utilizing previous research findings. Applications must include preliminary data to support feasibility of the study. Any unpublished, preliminary data provided should originate from the laboratory of the Principal Investigator (PI) or a member of the research team.

    ·            Continuity of Research: The Impact Award is intended to support established projects that have moved beyond the realm of basic research and have the potential to result in a near-term impact in clinical research or the clinic.

    ·            Data Evaluation: The proposed research should be rigorously designed to include a statistical plan and data analysis plan. The Impact Award is intended to have near-term relevance to patients; therefore, the statistical plan and data analysis plan should represent how significant the results and/or outcomes may be on patient outcomes.

    ·            Clinical Trial, if applicable: The clinical study must be initiated within the first year, including FDA Investigational New Drug/Investigational Device Exemption application submission plans within 60 days of the award.

    Grantor Contact Information: CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept